Humalog Mix 50 100IU/ml Cartridge is a premixed insulin formulation containing 50% insulin lispro and 50% insulin lispro protamine suspension, designed for the management of diabetes mellitus requiring insulin therapy. Insulin lispro is a rapid-acting insulin analogue that facilitates prompt reduction of postprandial blood glucose levels, while insulin lispro protamine provides an intermediate-acting insulin effect, ensuring sustained glycemic control. This biphasic insulin preparation is indicated for adult and pediatric patients with type 1 and type 2 diabetes mellitus who require both basal and prandial insulin coverage in a single injection. The cartridge is intended for use with compatible insulin delivery devices, allowing precise dosing and improved patient adherence. Humalog Mix 50 offers the advantage of simplified insulin regimens by combining rapid and intermediate-acting components, thereby reducing the number of daily injections. Dosage and administration should be individualized based on patient needs, glycemic response, and lifestyle factors, with careful monitoring to minimize the risk of hypoglycemia. This product should be stored under recommended conditions to maintain potency. As with all insulin therapies, patients should be educated on proper injection techniques, recognition and management of hypoglycemia, and the importance of regular blood glucose monitoring.